Etrolizumab
Product Specifications
CAS Number
1044758-60-2
Target
Integrin
Related Pathways
Cytoskeletal Signaling
Purity
0.989
Bioactivity
Etrolizumab (rhuMAb Beta7) is a humanized intestinal-selective anti-β7 integrin monoclonal antibody that selectively blocks the transport and retention of lymphocytes in the intestinal tract for the study of inflammatory bowel disease (IBD) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
414655-01 50 mg
2-[2- (6-Bromohexyloxy) ethoxymethyl]-1,3-dichlorobenzene-d4
Sign In for Pricing
View Details 414655-02 100 mg
2-[2- (6-Bromohexyloxy) ethoxymethyl]-1,3-dichlorobenzene-d4
Sign In for Pricing
View Details